IL10 and neoplasm: Notably, many studies report a shift toward an M2-like phenotype, characterized by an increased expression of IL-10 and VEGF, along with decreased TNF-α levels—features indicative of immunosuppressive reprogramming and a tumor-permissive immune profile [44].